German COVID-19 vaccine maker BioNTech, partner of US pharmaceutical group Pfizer, said on Monday it aims to produce two billion doses of its vaccine this year.
Follow our LIVE blog for latest updates of the novel coronavirus pandemic
"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," BioNTech said in a presentation.
Follow our full coverage of the coronavirus pandemic here.